Ayretrade, Inc. (SUMM) Receives FDA Rare Pediatric Disease for Ezutromid as DMD Treatment
Go back to Ayretrade, Inc. (SUMM) Receives FDA Rare Pediatric Disease for Ezutromid as DMD Treatment| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 3.55 -0.04 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.59 | 52 Week High | $19.75 | |||
| Open | $3.52 | 52 Week Low | $4.26 | |||
| Day High | $3.62 | P/E | N/A | |||
| Day Low | $3.44 | EPS | $0.00 | |||
| Volume | 1,407,270 | |||||
| AyreTrade, Inc. (AMEX: SUMM) | Delayed: 0.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $0.24 | |||
| Open | $40.78 | 52 Week Low | $0.02 | |||
| Day High | $0.06 | P/E | N/A | |||
| Day Low | $0.06 | EPS | $0.00 | |||
| Volume | 7,226,927 | |||||
